THE EFFECT OF ASSOCIATED CHRONIC OBSTRUCTIVE PULMONARY DISEASE ON THEINDICATORS OF PRECURSOR OFTYPE B NATURAURETIC PEPTIDE AND PROADRENOMEDULLIN AMONG PATIENTSWITH ISCHEMIC CA
-
Published:2019-04-30
Issue:1
Volume:9
Page:106-108
-
ISSN:2193-3863
-
Container-title:Archiv Euromedica
-
language:
-
Short-container-title:AREM
Author:
Myasoedova E.I.,Voronina L.P,Popov E.A.,Sevostyanova I.V.,Mukhambetova G.N.,Polunina O.S.,Perova N.Y.,Prokofieva T.V.
Abstract
The study showed that a statistically
significant increase of NT-proBNP levels (779,36 [473;
2193] pg/ml) and MR-proADM (1,72 [1,56; 1,98] nmol/l)
relative to the control values (69.90 [48.96; 91.00] pg / ml
and 0,49 [0,18; 0,58] nmol/l, respectively) is common for
the patients with ischemic cardiomyopathy. The presence of
concomitant chronic obstructive pulmonary disease among
the patients is associated with more pronounced increase
in the level of NT-proBNP (872,37 [510; 2355] pg/ml) and
MR-proADM (1,97 [1,75; 2,19] nmol/l) compared with a
group of patients with isolated ischemic cardiomyopathy.
This can be considered as one of the compensation links for
this comorbid combination
Publisher
European Scientific Society